Disparities starting adjuvant chemotherapy for locally advanced cervical cancer in the international, academic, randomised, phase 3 OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)

被引：0

作者：

Mileshkin, Linda ^{[1
]}

Barnes, Elizabeth ^{[2
]}

Moore, Kathleen ^{[3
]}

Gebski, Val ^{[2
]}

King, Madeleine ^{[4
]}

Narayan, Kailash ^{[5
]}

Kolodziej, Ilka ^{[2
]}

Sjoquist, Katrin ^{[2
]}

Fyles, Anthony ^{[6
]}

Small, William ^{[7
]}

Gaffney, David ^{[8
]}

Quinn, Michael ^{[1
]}

Andrews, John ^{[9
]}

Thompson, Spencer ^{[3
]}

Huh, Warner ^{[10
]}

Miller, David ^{[11
]}

Silvestro, Paul ^{[12
]}

Rischin, Danny ^{[1
]}

Stockler, Martin ^{[2
]}

Monk, Bradley ^{[13
]}

机构：

[1] Univ Melbourne, Dept Med Oncol, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[2] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia

[3] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA

[4] Univ Sydney, Sch Psychol, Fac Sci, Qual Life Off, Sydney, NSW, Australia

[5] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic, Australia

[6] Univ Toronto, Dept Radiat Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada

[7] Loyola Univ, Stritch Sch Med, Dept Radiat Oncol, Chicago, IL 60611 USA

[8] Univ Utah, Huntsman Canc Inst, Dept Radiat Oncol, Salt Lake City, UT USA

[9] Australian New Zealand Gynaecol Oncol Grp, Sydney, NSW, Australia

[10] Univ Alabama, Tuscaloosa, AL USA

[11] South Western Med Ctr Texas, Dallas, TX USA

[12] Women & Infants Rhode Isl, Providence, RI USA

[13] Creighton Univ, Sch Med, Div Gynecol Oncol Arizona Oncol, US Oncol Network,Univ Arizona,Coll Med,St Josephs, Phoenix, AZ USA

来源：

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

335

引用

页码：178 / 179

页数：2

共 48 条

[1] Disparities starting adjuvant chemotherapy for locally advanced cervix cancer in the international, academic, randomised, phase III OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)
Mileshkin, L.
Barnes, E.
Moore, K. N.
Gebski, V.
King, M.
Narayan, K.
Kolodziej, I. K.
Sjoquist, K.
Fyles, A.
Small, W.
Gaffney, D.
Quinn, M.
Andrews, J.
Thompson, S.
Huh, W.
Carlson, M.
Disilvestro, P. A.
Rischin, D.
Stockler, M. R.
Monk, B. J.
ANNALS OF ONCOLOGY, 2019, 30
[2] Racial disparities and survival outcome of patients with locally advanced cervix cancer in the international randomised phase 3 OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)
Lee, Yeh Chen
Castellano, Tara
Myers, Tashanna K. N.
Barnes, Elizabeth H.
Chase, Dana Meredith
McCormick, Colleen
Diamante, Katrina
Shannon, Catherine M.
Huh, Warner King
Lea, Jayanthi Sivasothy
Walker, Joan L.
Small, William, Jr.
Miller, Katherine
Govindarajulu, Geetha
Monk, Bradley J.
Stockler, Martin R.
Moore, Kathleen N.
Mileshkin, Linda R.
Bae-Jump, Victoria Lin
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[3] Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274).
Mileshkin, Linda R.
Moore, Kathleen N.
Barnes, Elizabeth
Gebski, Val
Narayan, Kailash
Bradshaw, Nathan
Lee, Yeh Chen
Diamante, Katrina
Fyles, Anthony W.
Small, William
Gaffney, David K.
Khaw, Pearly
Brooks, Susan
Thompson, J. Spencer
Huh, Warner King
Carlson, Matthew
Mathews, Cara Amanda
Rischin, Danny
Stockler, Martin R.
Monk, Bradley J.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (18)
[4] Staging locally advanced cervical cancer with FIGO 2018 versus FIGO 2008: Impact on overall survival and progression-free survival in the OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).
Mileshkin, Linda R.
Moore, Kathleen N.
Barnes, Elizabeth H.
Lee, Yeh Chen
Gebski, Val
Narayan, Kailash
Bradshaw, Nathan
Diamante, Katrina
Fyles, Anthony W.
Small, William
Gaffney, David K.
Khaw, Pearly
Brooks, Susan
Thompson, J. Spencer
Huh, Warner King
Carlson, Matthew
Robison, Katina
Rischin, Danny
Stockler, Martin R.
Monk, Bradley J.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[5] A phase III trial of adjuvant chemotherapy following chemoradialion as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: Outback (ANZGOG0902/G0G0274/RTOG1174).
Mileshkin, Linda R.
Narayan, Kailash
Moore, Kathleen N.
Rischin, Danny
King, Madeleine
Kolodziej, Ilka
Marlyn, Julie
Friedlander, Michael
Quinn, Michael
Small, William
Thomas, Gillian
Fyles, Anthony W.
Gebski, Vai
Stockier, Martin R.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[6] Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial
Mileshkin, Linda R.
Moore, Kathleen N.
Barnes, Elizabeth H.
Gebski, Val
Narayan, Kailash
King, Madeleine
Bradshaw, Nathan
Lee, Yeh Chen
Diamante, Katrina
Fyles, Anthony W.
Small, William, Jr.
Gaffney, David K.
Khaw, Pearly
Brooks, Susan
Thompson, J. Spencer
Huh, Warner K.
Mathews, Cara A.
Buck, Martin
Suder, Aneta
Lad, Thomas E.
Barani, Igor J.
Holschneider, Christine H.
Van Dyk, Sylvia
Quinn, Michael
Rischin, Danny
Monk, Bradley J.
Stockler, Martin R.
LANCET ONCOLOGY, 2023, 24 (05): : 468 - 482
[7] ADJUVANT CHEMOTHERAPY FOLLOWING CHEMORADIATION AS PRIMARY TREATMENT FOR LOCALLY ADVANCED CERVICAL CANCER COMPARED TO CHEMO-RADIATION ALONE: THE RANDOMISED PHASE 3 OUTBACK TRIAL
Moore, K.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A6 - A6
[8] A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The OUTBACK TRIAL.
Mileshkin, Linda R.
Narayan, Kailash
Moore, Kathleen N.
Rischin, Danny
Trimble, Edward Lloyd
Stockler, Martin R.
King, Madeleine
Kolodziej, Ilka
Martyn, Julie
Friedlander, Michael
Quinn, Michael
Shrivastava, Shyam K.
Small, William
Thomas, Gillian
Craighead, Peter S.
Gebski, Val
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[9] Adjuvant chemotherapy following definitive chemo radiation in patients with locally advanced cervical cancer: A phase II clinical trial
Hashemi, F. Amouzegar
ANNALS OF ONCOLOGY, 2017, 28
[10] A randomised phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: The GCIG INTERLACE trial
McCormack, M.
Rincon, D. Gallardo
Eminowicz, G.
Diez, P.
Farrelly, L.
Kent, C.
Hudson, E.
Panades, M.
Mathews, T.
Anand, A.
Persic, M.
Forrest, J.
Bhana, R.
Reed, N.
Drake, A.
Stobart, H.
Mukhopadhyay, A.
Hacker, A. M.
Hackshaw, A.
Ledermann, J. A.
ANNALS OF ONCOLOGY, 2023, 34 : S1276 - S1276

← 1 2 3 4 5 →